Setpoint medical reports positive results from two bioelectronic medicine studies at north american neuromodulation society meeting
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Loading...
SetPoint Medical, a clinical-stage biomedical technology company developing an implantable bioelectronic medicine therapy for chronic inflammatory diseases, presented positive data from two
clinical studies in rheumatoid arthritis (RA) and Crohn’s disease (CD) at the North American Neuromodulation Society (NANS) annual meeting, held January 11-14, 2018 in Las Vegas. Both
studies use an implanted device to deliver digital doses of electricity, stimulating the vagus nerve with timed electrical pulses, activating the body’s natural Inflammatory Reflex to
produce a systemic anti-inflammatory effect. SetPoint Medical Reports Positive Results from Two Bioelectronic Medicine Studies at North American Neuromodulation Society Meeting